INS CD-STUTTERING COVERAGE
HB3325 would require certain Illinois health insurance policies and managed care plans to cover speech therapy for stuttering when the plan covers habilitative services, rehabilitative services, or both. The bill defines habilitative and rehabilitative speech therapy and specifies that coverage must apply to treatment for stuttering regardless of whether the stuttering is classified as developmental. It applies to group and individual accident and health policies and managed care plans that are amended, delivered, issued, or renewed on or after January 1, 2027.
The bill also extends the same coverage requirement to a broad set of public and quasi-public coverage arrangements, including the State Employees Group Insurance Act, county and municipal self-insured plans, school employee insurance, health maintenance organizations, limited health service organizations, voluntary health services plans, and the Illinois Public Aid Code (Medicaid). It adds a new Section 356z.80 to the Illinois Insurance Code and makes conforming changes across multiple statutes so that stuttering treatment is treated as a required health benefit in those programs.
HB3325 would amend the Illinois Insurance Code and several related benefit statutes to create a new mandated coverage category for stuttering treatment through speech therapy. It would require insurers and public plans that already cover habilitative or rehabilitative services to include speech therapy for stuttering, prohibit annual visit caps and disease-based limits for the required coverage, bar utilization review and prior authorization for the benefit, and require telehealth coverage for the service. The bill also makes the mandate applicable to state employee, local government, school, HMO, limited health service, voluntary health services, and Medicaid coverage, and it declares the mandate an unfunded state requirement under the State Mandates Act.
Based on the bill text and the absence of recorded committee testimony or votes in the provided materials, the overall sentiment appears supportive and straightforward rather than contested. The measure is framed as a targeted health coverage expansion for people who stutter, with detailed coverage protections suggesting an intent to ensure meaningful access rather than a symbolic benefit. No opposing arguments, amendments, or recorded roll-call concerns are included in the available context.
The main policy issues embedded in the bill are cost, scope, and administrative burden. Insurers and public-plan administrators could object to the mandate because it requires coverage without annual limits, without prior authorization, and across multiple plan types, including Medicaid and self-insured public employers. Another possible point of contention is the bill’s broad application to habilitative and rehabilitative coverage, which may raise questions about how often stuttering therapy is medically necessary and how telehealth services should be delivered. The bill anticipates a federal preemption/ACA funding issue by making the section inoperative if federal action would require state defrayal, but no specific stakeholder opposition is shown in the provided record.